7,824 reports of this reaction
4.7% of all VARENICLINE TARTRATE reports
#3 most reported adverse reaction
ABNORMAL DREAMS is the #3 most commonly reported adverse reaction for VARENICLINE TARTRATE, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 7,824 FDA adverse event reports linking VARENICLINE TARTRATE to ABNORMAL DREAMS. This represents approximately 4.7% of all 167,559 adverse event reports for this drug.
VARENICLINE TARTRATE has an overall safety score of 85 out of 100. Patients taking VARENICLINE TARTRATE who experience abnormal dreams should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ABNORMAL DREAMS is moderately reported among VARENICLINE TARTRATE users, representing a notable but not dominant share of adverse events.
In addition to abnormal dreams, the following adverse reactions have been reported for VARENICLINE TARTRATE:
The following drugs have also been linked to abnormal dreams in FDA adverse event reports:
ABNORMAL DREAMS has been reported as an adverse event in 7,824 FDA reports for VARENICLINE TARTRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ABNORMAL DREAMS accounts for approximately 4.7% of all adverse event reports for VARENICLINE TARTRATE, making it one of the most commonly reported side effect.
If you experience abnormal dreams while taking VARENICLINE TARTRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.